3553 results for «2257»

Filter By

3553 results

TAV-in-TAV

08 Feb 2025 – From PCR Tokyo Valves 2025

Watch this PCR Tokyo Valves 2025 session on TAV-in-TAV to discover essential insights on optimizing the procedure. Learn how CT analysis and precise measurements are critical for success, and why coronary protection, chimney stenting, and leaflet modification must be considered in high-risk cases. Experts discuss key...

TAV-in-TAV

Lifetime management - First valve choice matters

08 Feb 2025 – From PCR Tokyo Valves 2025

In this expert-led session, explore new frontiers in TAVI, focusing on bicuspid aortic valves, small annulus, and the risk of secondary interventions. Gain insights from the latest randomized trials (RHEIA) and registry data (CAvEAT), with real-world case discussions highlighting their clinical impact.

Lifetime management - First valve choice matters

Management of paravalvular leak

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this comprehensive session on the management of paravalvular leaks, a challenging complication following surgical or transcatheter valve replacements. Discover insights into managing post-operative pulmonary edema, percutaneous closure of left ventricular septal defects, and the nuances of mitigating recurrent paravalvular leaks. Dive into complex cases involving...

Management of paravalvular leak

TAVI complex cases: intravascular hemolysis, Heyde syndrome & more

08 Feb 2025 – From PCR Tokyo Valves 2025

This session presents a diverse array of complex TAVI cases, from interventions for paravalvular leak-induced intravascular hemolysis to cases of severe aortic tortuosity, calcification hindering valve expansion, and successful TAVI in patients with Heyde syndrome and HIV infection. Gain valuable insights into navigating these challenging scenarios.

TAVI complex cases: intravascular hemolysis, Heyde syndrome & more

TAVI and coronary artery disease

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the complex interplay between TAVI and coronary artery disease in this comprehensive session. Explore the decision-making process for optimal sequencing of PCI and TAVI, and examine cases of acute myocardial infarction due to coronary embolism and delayed coronary obstruction following TAVI. Gain insights into...

TAVI and coronary artery disease

Post-procedure complications: leaflet thrombus, hemolytic anemia & more

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to discover a range of post-procedure complications that can arise after TAVI, including subacute leaflet thrombus, hemolytic anemia after surgical aortic valve replacement, late migration of papillary fibroelastoma, sinus sequestration, delayed left main occlusion, and high-grade atrioventricular block. Additionally, learn about techniques to...

Post-procedure complications: leaflet thrombus, hemolytic anemia & more

High-risk TAVI

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a...

High-risk TAVI

Redo mitral procedures

08 Feb 2025 – From PCR Tokyo Valves 2025

Explore this session to gain insights into the management of recurrent mitral regurgitation after percutaneous mitral valve interventions. Discover various redo procedures, including the use of the PASCAL system for recurrent MR after MitraClip, redo M-TEER for torn posterior leaflet, and successful redo TEER and MitraClip...

Redo mitral procedures

The value of WATCHMAN therapy - Who should we treat?

08 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...

The value of WATCHMAN therapy - Who should we treat?

Combined valve disease

09 Feb 2025 – From PCR Tokyo Valves 2025

This session delves into the management of combined valve disease, covering topics such as transcatheter tricuspid valve replacement and valve-in-valve/valve-in-ring implantation in high-risk patients, the importance of CT imaging analysis in predicting true mitral stenosis in TAVI patients, the clinical outcomes of mild-to-moderate mixed aortic valve...

Combined valve disease

TAVI in challenging anatomy

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the challenges of TAVI in complex anatomies, including cases of extremely horizontal aorta, extra-large aortic annulus with calcified amorphous tumour-like mass, severe atherosclerotic aorta complicated by severe aortic stenosis, transfemoral TAVI for severe aortic regurgitation with Stanford type B aortic dissection, and optimal TAVI...

TAVI in challenging anatomy

Mastering techniques from basic to complex - TAVI basics

07 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the fundamentals of TAVI (Transcatheter Aortic Valve Implantation) in this comprehensive session. Explore the importance of commissural alignment, learn strategies to mitigate the risk of coronary occlusion, and discover techniques to manage unexpected hypotension during TAVI procedures. Equip yourself with the essential knowledge to...

Mastering techniques from basic to complex - TAVI basics

TAVI in bicuspid anatomy

08 Feb 2025 – From PCR Tokyo Valves 2025

Discover the key insights from this PCR Tokyo Valves 2025 session focused on TAVI in bicuspid anatomy. Learn why TAVI for bicuspid aortic stenosis (AS) shows comparable long-term outcomes to tricuspid AS in registry data, and understand the importance of patient selection, precise valve sizing, and...

TAVI in bicuspid anatomy

PCR London Valves innovations

21 Nov 2021 – From PCR London Valves 2021

Discover the first-in-man experience with a mitral D-shaped semi-rigid annuloplasty system, find out more about the novel 3D single-piece transcatheter valve designed for lifetime patient management, know more about the first dedicated transcatheter leaflet splitting device from bench to FIH, and much more in this session...

PCR London Valves innovations

Clinical scenarios

21 Nov 2021 – From PCR London Valves 2021

The PCR London Valves 2021 session offers a variety of interesting clinical scenarios, including a chimney stent as a coronary protection technique in TAVI, an acquired thrombocytopenia after TAVR to predict adverse outcomes, or even a calcified raphe predict adverse effect in bicuspid aortic stenosis patients...

Clinical scenarios

Outcomes of TAVI devices

21 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session on TAVI compiles the results of various clinical studies conducted on different valve models on the market today and in the future: J-valve, Acurate Neo-2, Perimount P 2900, and many others.

Outcomes of TAVI devices

Tailoring mitral and tricuspid dedicated clip therapies by unlocking their full potential

22 Nov 2021 – From PCR London Valves 2021

Plunge into the universe of mitral and tricuspid in this PCR London Valves 2021 session, and learn how to optimize patient selection and tailor our procedural strategy, understand how to optimize patient outcomes with dedicated devices, and experience how to maximize the use of the G4...

Tailoring mitral and tricuspid dedicated clip therapies by unlocking their full potential

Stroke prevention in TAVI

21 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, learn about the standard use of the cerebral embolism protection device in routine TAVR, find out more about the PROTEMBO C trial, and take a close look at the TriGUARD 3 device.

Stroke prevention in TAVI

The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes

21 Nov 2021 – From PCR London Valves 2021

In this session from the PCR London Valves 2021 Congress, find out more about the new Navitor valve and FlexNav delivery system, discover how to achieve favourable patient outcomes, and learn how choosing a device can impact patient lifetime management.

The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes

TAVI access

21 Nov 2021 – From PCR London Valves 2021

Watch this series of videos from PCR London Valves 2021 for clinical outcomes after single access transfemoral transcatheter aortic valve implantation, to consider transcaval TAVI as a reliable alternative, to appreciate a fully percutaneous subclavian approach for TAVI, and much more!

TAVI access
Didn’t find what you were looking for?